For example, the inhibition of FOXK1 expression in hepatocellular carcinoma cells reduces cellular aerobic glycolysis and cell viability by impeding the transduction of the AKT/mTOR signaling pathway, a function distinct from that of Foxk1/2 in normal liver cells (36). Here, FOXK1 is linked to hepatocellular carcinoma.